How to Read Peptide Testing Documentation and COAs

A testing document is most useful when it can be connected to a specific material, batch, method, and result. A polished certificate alone is not proof of every quality characteristic, and one analytical result should not be stretched beyond the question that the method was designed to answer.

What is a certificate of analysis?

A certificate of analysis—usually shortened to COA—is a summary of analytical information associated with a material or batch. Depending on its scope, it may list identity, assay, purity, impurities, appearance, water content, or other defined tests. The document should state what was tested and what the reported result means under the named procedure.

Formal quality guidance provides a useful benchmark for document structure. The FDA’s ICH Q7 guidance for active pharmaceutical ingredients says a certificate should identify the material and batch, list the tests performed, show acceptance limits and numerical results where applicable, and be dated and signed by authorized quality personnel. That guidance applies in a regulated API-manufacturing context; it is cited here as an analytical-documentation reference, not as a claim that a research catalog or product is approved as a drug.

1. Match the document to the product and batch

Begin with the fields that connect the paper to the physical item. The compound name, labeled strength or format, and batch or lot reference should align with the product record. A report for a similarly named compound, another strength, or a different batch cannot automatically describe the item being reviewed.

Check the label and listing independently. ELMNTPEP product pages identify the compound, labeled amount, format, current price, and stock state. Testing documentation is available, and certificates of analysis will be posted to the site as they become available.

2. Identify the question each test answers

Identity, chromatographic purity, assay or content, and impurity testing are related but distinct analytical questions. A method that supports one conclusion may not establish the others. For example, a chromatographic area percentage describes the relative response observed under that chromatographic procedure. It should not be treated automatically as proof of material identity or as a direct measurement of the total amount in a vial.

3. Look for the method—not only the percentage

A percentage without a method, sample reference, or reporting context is difficult to interpret. Useful documentation identifies the technique or procedure used and gives enough context to understand the reported result. Depending on the analytical question, a laboratory may use chromatography, mass spectrometry, spectroscopy, water analysis, or another appropriate procedure.

The final ICH Q2(R2) analytical-validation guideline frames validation around whether a procedure is fit for its intended purpose. It discusses characteristics such as specificity or selectivity, accuracy, precision, and the reportable range. Those concepts explain why the method and its intended use matter as much as the headline result.

4. Separate a result from its specification

A result is the value reported for the sample. A specification or acceptance limit is the predefined criterion used to evaluate that result. Strong documentation shows both when applicable. A statement such as “passes” is easier to assess when the document also identifies the test, the limit, and the observed value.

Do not assume that every laboratory uses identical procedures, reporting thresholds, or acceptance criteria. If two suppliers publish numbers generated under different methods, the values may not be directly comparable. Comparison requires attention to sample preparation, reference materials, instrument conditions, calculations, and reporting limits.

5. Check the laboratory, date, and authorization

A testing record should identify who produced or authorized it and when. Review the laboratory name, report or analysis date, document number, version, and signature or electronic authorization where provided. If a subcontract laboratory performed a test, clear identification helps readers understand the source of the result.

Health Canada’s drug-product GMP guidance states that subcontracted test results on a certificate should be identified with the laboratory that performed the testing. Again, this is a regulatory reference point for document review—not a statement that every research material falls within that drug-product framework.

6. Read chromatograms as supporting records

A chromatogram can provide useful supporting detail when the sample, method, peaks, integration, and calculations are connected to the certificate. Look for a sample identifier, run date, method reference, axes, peak table, and a clear relationship between the instrument output and the summarized result.

A graph image by itself is not a complete certificate. Without the sample identity, batch, procedure, calculation, and authorization, a chromatogram can be difficult to connect to the product. Conversely, a one-page certificate may summarize a much larger analytical record, so the absence of every raw-data page does not automatically invalidate the summary. The practical question is whether the document contains enough traceable detail for the claim being made.

7. Watch for common documentation red flags

• No batch or lot identifier.
• The compound name or strength does not match the listing.
• A headline purity number appears without a method or result table.
• The report date, laboratory, or authorization is missing.
• The document shows only a generic template or graph with no sample connection.
• One result is used to imply identity, purity, exact content, sterility, and stability all at once.
• The supplier makes an absolute guarantee broader than the document supports.

A practical review workflow

1. Match the product name, format, and batch reference.
2. List every test actually reported.
3. Write down the method or technique associated with each test.
4. Separate the numerical result from the acceptance criterion.
5. Confirm the laboratory, date, report identifier, and authorization.
6. Check whether the conclusion stays within the scope of the method.
7. Compare the document with the product page, label, and current testing-information page.

Where this fits in supplier evaluation

Testing records are one part of a professional research catalog. Product-title accuracy, image alignment, single-vial or kit format, live inventory, backorder controls, shipping, payment information, research-use boundaries, and consistent policies also matter. Use the full research peptide supplier evaluation guide to review those signals together.

Primary guidance referenced

• ICH Q2(R2): Validation of Analytical Procedures—final harmonized guideline on analytical-procedure validation.
• FDA / ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients—certificate and laboratory-record considerations in an API context.
• Health Canada GUI-0001: Good Manufacturing Practices Guide for Drug Products—Canadian regulatory guidance on laboratory controls and certificates.

Research use notice: This guide explains how to review analytical documentation in a laboratory-research context. It is not medical, dosing, administration, or therapeutic guidance. ELMNTPEP products are not intended for human or veterinary use.